Related Experiment Video
Updated: Feb 24, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
16.3K
Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
M J Alvarez Cubero1, J A Lorente2,3, I Robles-Fernandez2
1GENYO. Centre for Genomics and Oncological Research, Pfizer, University of Granada, Andalusian Regional Government, Av. de la Ilustración 114, 18016, Granada, Spain. mjesusac@ugr.es.
Methods in Molecular Biology (Clifton, N.J.)
|August 19, 2017
Summary
Liquid biopsies, particularly circulating tumor cells (CTCs), offer promising avenues for cancer detection and progression monitoring. Accurately capturing and analyzing these rare cells is crucial for advancing cancer diagnostics.
Area of Science:
- Oncology
- Biomedical Engineering
- Molecular Diagnostics
Background:
- Cancer remains a leading global disease with many unknown initiation processes.
- Liquid biopsies provide a minimally invasive approach to study cancer progression.
- Circulating tumor cells (CTCs) are key components of liquid biopsies, originating from primary tumors and entering the bloodstream.
Purpose of the Study:
- To highlight the significance of liquid biopsies in cancer detection and monitoring.
- To discuss the challenges associated with the rarity of CTCs in blood samples.
- To review various methodologies employed for CTC capture and analysis.
Main Methods:
- Focus on the principles and techniques for isolating CTCs from blood.
- Description of analytical methods for characterizing captured CTCs.
- Exploration of technologies designed to overcome the challenge of CTC rarity.
Main Results:
- CTCs are present at very low frequencies (1-10 cells/mL in metastatic disease), posing a significant detection challenge.
- The rarity of CTCs necessitates highly sensitive and specific capture and analysis techniques.
- Accurate methodologies are essential for reliable CTC detection and subsequent clinical application.
Conclusions:
- Liquid biopsies, especially CTC analysis, hold substantial potential for early cancer detection and tracking disease progression.
- Advancements in CTC isolation and analysis technologies are critical for realizing the full clinical utility of liquid biopsies.
- Further research into CTCs can elucidate cancer biology and improve patient outcomes.
